The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
eFFECTOR Therapeutics, Inc. | Common Stock | 28202V108 | 615,316 | 1,025,697 | SH | SOLE | 1,025,697 | 0 | 0 | ||
PMV Pharmaceuticals, Inc. | Common Stock | 69353Y103 | 6,073,884 | 989,232 | SH | SOLE | 989,232 | 0 | 0 | ||
Cyteir Therapeutics, Inc. | Common Stock | 23284P103 | 6,985,184 | 2,459,572 | SH | SOLE | 2,459,572 | 0 | 0 | ||
Homology Medicines, Inc. | Common Stock | 438083107 | 74,880 | 64,000 | SH | SOLE | 64,000 | 0 | 0 | ||
Ikena Oncology, Inc. | Common Stock | 45175G108 | 116,187 | 26,833 | SH | SOLE | 26,833 | 0 | 0 | ||
Precision BioSciences, Inc. | Common Stock | 74019P108 | 383,592 | 1,123,913 | SH | SOLE | 1,123,913 | 0 | 0 | ||
Selecta Biosciences, Inc. | Common Stock | 816212104 | 914,296 | 862,543 | SH | SOLE | 862,543 | 0 | 0 | ||
Spero Therapeutics, Inc. | Common Stock | 84833T103 | 301,375 | 249,070 | SH | SOLE | 249,070 | 0 | 0 | ||
Centessa Pharmaceuticals plc | Sponsored ADS | 152309100 | 19,006,369 | 2,937,615 | SH | SOLE | 2,937,615 | 0 | 0 | ||
Aerovate Therapeutics Inc. | Common Stock | 008064107 | 8,193,050 | 603,762 | SH | SOLE | 603,762 | 0 | 0 | ||
Graphite Bio | Common Stock | 38870X104 | 1,007,644 | 406,308 | SH | SOLE | 406,308 | 0 | 0 | ||
Vor Biopharma Inc. | Common Stock | 929033108 | 794,394 | 374,714 | SH | SOLE | 374,714 | 0 | 0 |